Krishna Prasad
- Pharmacology top 10%
- Accounting top 10%
- Corporate Finance and Governance 7
- Auditing, Earnings Management, Governance 4
- Risk Management in Financial Firms 2
- Working Capital and Financial Performance 2
- Strategy and Management top 10%
- Corporate Social Responsibility Reporting 3
-
- Lymphoma Diagnosis and Treatment 4
-
- Pain Management and Opioid Use 2
-
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Nandan PrabhuMarkus PaulmichlMarisa Papaluca‐AmatiFalk EhmannShyamala GuruvareMarc MaliepaardAdrián LLerenaMagnus Ingelman‐Sundberg
- Journals
- Clinical Cancer Research (1 paper)Research in International Business and Finance (1 paper)The Pharmacogenomics Journal (1 paper)
- Partner nations
- IndiaUnited StatesMalaysia
In The Last Decade
Krishna Prasad
23 papers receiving 275 citations
Peers
Comparison fields: 5 of 83
- Pharmacology 75
- Accounting 58
- Strategy and Management 69
- Marketing 34
- Finance 24
Countries citing papers authored by Krishna Prasad
This map shows the geographic impact of Krishna Prasad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Prasad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Prasad more than expected).
Fields of papers citing papers by Krishna Prasad
This network shows the impact of papers produced by Krishna Prasad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Prasad. The network helps show where Krishna Prasad may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Krishna Prasad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2022 | 1 | |
| 7 | 2022 | 57 | |
| 8 | 2021 | 12 | |
| 9 | 2019 | 4 | |
| 10 | 2019 | 10 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2015 | 96 | |
| 14 | 2014 | 11 | |
| 15 | 2013 | 0 | |
| 16 | 2013 | 2 | |
| 17 | 2013 | 1 | |
| 18 | 2012 | 4 | |
| 19 | Role of regulatory agencies in translating pharmacogenetics to the clinics. | 2009 | 3 |
| 20 | 1968 | 0 |
About Krishna Prasad
Krishna Prasad is a scholar working on Accounting, Finance and Anesthesiology and Pain Medicine, having authored 29 papers that have together received 290 indexed citations. Recurring topics across this work include Corporate Finance and Governance (7 papers), Lymphoma Diagnosis and Treatment (4 papers), Auditing, Earnings Management, Governance (4 papers), Corporate Social Responsibility Reporting (3 papers), Risk Management in Financial Firms (2 papers), Working Capital and Financial Performance (2 papers), Pain Management and Opioid Use (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pharmacology (75 citations), Accounting (58 citations) and Strategy and Management (69 citations). Krishna Prasad has collaborated with scholars based in India, United States and Malaysia. Frequent co-authors include Nandan Prabhu, Markus Paulmichl, Marisa Papaluca‐Amati, Falk Ehmann, Shyamala Guruvare, Marc Maliepaard, Adrián LLerena, Magnus Ingelman‐Sundberg, Weng Marc Lim and Satish Kumar. Their work appears in journals such as Clinical Cancer Research, Research in International Business and Finance and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.